Company performance
Add to research
Current Price
as of Apr 21, 2025$1.02
P/E Ratio
N/A
Market Cap
$3.35M
Description
Add to research
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Metrics
Add to research
Overview
- HQSolana Beach, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerARTL
- Price$1.02+6.94%
Trading Information
- Market cap$3.35M
- Float99.17%
- Average Daily Volume (1m)1,208,280
- Average Daily Volume (3m)413,527
- EPS-$3.05
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$9.83M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$10.11M
- EV$1.18M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.17
- Debt/Equity3.64
Documents
Add to research
SEC Filings
Factset Street Account